Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

PATH BGC

K-Number: K260938 · 2026-04-15

ApplicantCrossroads Neurovascular, Inc.
Decision Date2026-04-15
Product CodeQJP
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

PATH BGC is a medical device manufactured by Crossroads Neurovascular, Inc.. It received FDA 510(k) clearance on 2026-04-15 under approval number K260938. The device is classified under product code QJP. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the PATH BGC?

PATH BGC is a medical device that received FDA 510(k) clearance on 2026-04-15. It is manufactured by Crossroads Neurovascular, Inc.. The 510(k) number is K260938.

When was PATH BGC approved by the FDA?

PATH BGC received FDA 510(k) clearance on 2026-04-15, under approval number K260938.

What company makes PATH BGC?

PATH BGC is manufactured by Crossroads Neurovascular, Inc..

What is the FDA product code for PATH BGC?

The FDA product code for PATH BGC is QJP.

Other Devices by Crossroads Neurovascular, Inc.

K242392PATH BGC

Related Devices (Code: QJP)

K203043Route 92 Medical 070 Access SystemRoute 92 Medical, Inc. K201682RIST Radial Access CatheterRist Neurovascular, Inc. K201518Route 92 Medical 088 Access SystemRoute 92 Medical K201076Anchor Dual Lumen Guidewire CatheterAqure Medical, Inc. K200910BOSS Balloon Guide CatheterMarblehead Medical K200417RIST Radial Access CatheterRist Neurovascular, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑